这是一张logo图片

big data and AI company with a focus on smart pathology and medicine

Industry Background
  • Partner with medical diagnostic institutions
  • Work alongside a team of pathologists and healthcare experts
Deep Integration
  • Healthcare and technology experts
  • Strong customer adoption capabilities
AI Empowerment
  • Dedicated big data and AI professionals
  • Collaboration with Fortune 500 companies
Leading the formulation of
NMPA cervical cell data
Leading the construction of Large model
corpus in the medical industry
Establish Histopathology
Pan-cancer diagnosis large model
Publish Millions Clinical
auxiliary diagnostic report
In-depth service overseas
Large medical group

Pioneering Advantage

  • High-quality Dataset

  • Core Algorithm

  • Leading Product

  • Professional Team

PATHOAI

PathoAI is big data and AI company with a focus on smart pathology and medicine,focusing on the development and application of artificial intelligence products and overall solutions for in vitro diagnostics and pharmaceutical R&D pathology CROs,the integrated team at PathoAI has generated advancements that allow doctors to effectively optimize patient outcomes. Under the guidance of its pool of expert pathologists and data scientists, PathoAI continuously strives to define industry data standards that simultaneously adhere to guidelines governed by local regulatory authorities. PathoAI aims to provide patients with accurate diagnoses and thereon avail them to effective treatments. This is achieved through its state-of-the-art digital pathology and AI-powered technology.

Learn more

Core Products

Cooperative / Alliance Unit

浙江大学医学院附属邵逸夫医院

首都医科大学附属北京朝阳医院

中国科学院大学附属浙江省肿瘤医院

浙江求是数理医学研究院

浙江省第一医院

浙江大学医学院附属第二医院

宁波临床病理诊断中心

广东省人民医院

复旦大学附属肿瘤医院

郑州人民医院

四川大学华西医院

河南省人民医院

南昌大学第一附属医院

中国医学科学院肿瘤医院

北京医院

中国医科大学附属第一医院

哈尔滨医科大学附属第一医院

扬州市第一人民医院

福建省妇幼保健院

英国思克莱德大学

浙ICP备2021013851号

COPYRIGHT © 2021 PathoAI